Investing.com-- Most Asian currencies moved little on Friday and were nursing losses for the week, while the dollar steadied ...

Shares in European vaccine-makers fell in early trade on Friday after U.S. President-elect Donald Trump said he had selected ...

Home prices in major Chinese cities posted narrower declines in October when compared with September as Beijing's property support measures start to kick in. Average new home prices in 70 Chinese ...

Stocks slid on Thursday as Fed Chair Jerome Powell signaled that policymakers don't need to be in a hurry to cut rates.

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

AstraZeneca PLC Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - AZN ...

Also in today’s newsletter, US regulators plan to investigate Microsoft’s cloud business, and Disney-Reliance Indian media giant says TV ‘is not dead’ ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...

The CNS Summit Digital Innovation Index, developed in conjunction with IDEA Pharma, was revealed at the CNS Summit annual meeting on November 13. The index evaluates and ranks biopharma companies' ...

Merck on Thursday said it has secured an exclusive global license to develop, manufacture and commercialize LM-299, an investigational PD-1/VEGF bispecific antibody from Shanghai-based LaNova that is ...

Merck (MRK) stock will be in focus as company inks deal worth up to $3.3B to buy licensing rights to a cancer candidate ...